Literature DB >> 15138587

Potentiation of induction of apoptosis by sequential treatment with cisplatin followed by 5-fluorouracil in human oral cancer cells.

Masayuki Azuma1, Koji Harada, Tetsuya Tamatani, Katsumi Motegi, Yuki Ashida, Mitsunobu Sato.   

Abstract

We examined the mechanism involved in the induction of apoptosis in human oral cancer (B88) cells with 5-fluorouracil (5-FU) and cisplatin (CDDP) combination. Three different combination treatment sequences were evaluated: i) 5-FU administered simultaneously with CDDP for 72 h (sequence I); ii) CDDP administered for 24 h before 5-FU treatment for 48 h (sequence II); and iii) 5-FU administered for 24 h before CDDP treatment for 48 h (sequence III). When combining the two drugs at doses 40% of their respective cytotoxicity, the growth-suppressing ratios were 49, 55, and 40% in sequences I, II, and III, respectively. Caspase 3 was significantly activated in sequence II as compared to its level of activation in sequence I or III. The mitochondrial release of cytochrome c was much greater in sequence II than in sequence III. In addition, activation of caspase 8 was most strongly activated in sequence II as compared with sequences I and III. Activation of caspase-9 was also observed in sequence II, and, to a lesser extent, in sequence III. Finally, although Bcl-2 was reduced in sequence II, no significant change was observed in sequence III. Accordingly, the data presented here demonstrate that sequence II showing a significant increase in the induction of apoptosis of cancer cells, is superior to sequences I and III.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138587

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Escopoletin treatment induces apoptosis and arrests cell cycle at G0/G1 phase in the oral squamous cancer cell lines.

Authors:  Zhuo Wang; Hua-Yan Guo; Yuan-Liang Huang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Pseudomonas aeruginosa exotoxin A reduces chemoresistance of oral squamous carcinoma cell via inhibition of heat shock proteins 70 (HSP70).

Authors:  Sang Rye Park; Kyoung Duk Lee; Uk Kyu Kim; Young Gi Gil; Kyu Seon Oh; Bong Soo Park; Gyoo Cheon Kim
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 3.052

3.  p22phox confers resistance to cisplatin, by blocking its entry into the nucleus.

Authors:  Chih-Chang Hung; Chen-Yu Chien; Wei-Fan Chiang; Chang-Shen Lin; Tzyh-Chyuan Hour; Hau-Ren Chen; Ling-Feng Wang; Jenq-Yuh Ko; Chi-Hua Chang; Jeff Yi-Fu Chen
Journal:  Oncotarget       Date:  2015-02-28

4.  Direct Binding of Cisplatin to p22phox, an Endoplasmic Reticulum (ER) Membrane Protein, Contributes to Cisplatin Resistance in Oral Squamous Cell Carcinoma (OSCC) Cells.

Authors:  Chih-Chang Hung; Fu-An Li; Shih-Shin Liang; Ling-Feng Wang; I-Ling Lin; Chien-Chih Chiu; Chiu-Hsien Lee; Jeff Yi-Fu Chen
Journal:  Molecules       Date:  2020-08-21       Impact factor: 4.411

Review 5.  Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer.

Authors:  Koji Harada; Tarannum Ferdous; Yoshiya Ueyama
Journal:  Jpn Dent Sci Rev       Date:  2016-12-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.